Stock DRMA DERMATA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Dermata Therapeutics, Inc.

Equities

DRMA

US2498454055

Delayed Nasdaq
Other stock markets
 01:51:13 2024-06-12 pm EDT 		5-day change 1st Jan Change
3.12 USD -0.32% Intraday chart for Dermata Therapeutics, Inc. -16.10% -65.90%
May. 15 Dermata Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 21 Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Adjusts Price Target on Dermata Therapeutics to $4 From $16, Keeps Buy Rating
MT
DERMATA THERAPEUTICS : Brookline Capital Starts Dermata Therapeutics at Buy with $14 Price Target
MT
DERMATA THERAPEUTICS : Maxim Starts Dermata Therapeutics at Buy with $9 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRMA Stock
  4. News Dermata Therapeutics, Inc.
  5. Analyst Reco.